Potential benefits of volumetric modulated arc therapy to reduce the incidence of ≥ grade 2 radiation pneumonitis in radiotherapy for locally advanced non-small cell lung cancer patients.

Nobuki ImanoTomoki KimuraDaisuke KawaharaRiku NishiokaWataru FukumotoReo KawanoKatsumaro KuboTsuyoshi KatsutaYuki TakeuchiIkuno NishibuchiYuji MurakamiYasushi HorimasuTakeshi MasudaKazunori FujitakaNoboru HattoriYasushi Nagata

Published in: Japanese journal of clinical oncology (2021)

We identified factors associated with ≥ grade 2 radiation pneumonitis in radiotherapy for patients with locally advanced non-small cell lung cancer. Volumetric modulated arc therapy has potential benefits to reduce the risk of ≥ grade 2 radiation pneumonitis.

Keyphrases

advanced non small cell lung cancer
radiation induced
early stage
interstitial lung disease
radiation therapy
locally advanced
cell therapy
single cell
risk factors
human health
stem cells
systemic sclerosis
rheumatoid arthritis
rectal cancer
climate change
idiopathic pulmonary fibrosis
smoking cessation